Comparison of hypoxia-induced pulmonary hypertension rat models caused by different hypoxia protocols

References

• Galiè N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019;53(1):1802148. doi:10.1183/13993003.02148-2018
   PubMed Web of Science ®Google Scholar
• Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. doi:10.1183/13993003.01913-2018
   PubMed Web of Science ®Google Scholar
• Schreier D, Hacker T, Song G, Chesler N. The role of collagen synthesis in ventricular and vascular adaptation to hypoxic pulmonary hypertension. J Biomech Eng. 2013;135(2):021018. doi:10.1115/1.4023480
   PubMed Web of Science ®Google Scholar
• Liu P, Yan S, Chen M, et al. Effects of baicalin on collagen Ι and collagen ΙΙΙ expression in pulmonary arteries of rats with hypoxic pulmonary hypertension. Int J Mol Med. 2015;35(4):901–908. doi:10.3892/ijmm.2015.2110
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. doi:10.1093/eurheartj/ehv317
   PubMed Web of Science ®Google Scholar
• Boucherat O, Agrawal V, Lawrie A, Bonnet S. The latest in animal models of pulmonary hypertension and right ventricular failure. Circ Res. 2022;130(9):1466–1486. doi:10.1161/circresaha.121.319971
   PubMed Web of Science ®Google Scholar
• Dignam JP, Scott TE, Kemp-Harper BK, Hobbs AJ. Animal models of pulmonary hypertension: Getting to the heart of the problem. Br J Pharmacol. 2022;179(5):811–837. doi:10.1111/bph.15444
   PubMed Web of Science ®Google Scholar
• Ranchoux B, Harvey LD, Ayon RJ, et al. Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series). Pulm Circ. 2018;8(1):2045893217752912. doi:10.1177/2045893217752912
   Web of Science ®Google Scholar
• Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99(7):675–691. doi:10.1161/01.RES.0000243584.45145.3f
   PubMed Web of Science ®Google Scholar
• Thenappan T, Chan SY, Weir EK. Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2018;315(5):H1322–h1331. doi:10.1152/ajpheart.00136.2018
   PubMed Web of Science ®Google Scholar
• Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. The right ventricle under pressure: cellular and ­molecular mechanisms of right-heart failure in pulmonary hypertension. Chest. 2009;135(3):794–804. doi:10.1378/chest.08-0492
   PubMed Web of Science ®Google Scholar
• Maarman G, Lecour S, Butrous G, Thienemann F, Sliwa K. A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet? Pulm Circ. 2013;3(4):739–756. doi:10.1086/674770
   PubMed Web of Science ®Google Scholar
• Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009;297(6):L1013–32. doi:10.1152/ajplung.00217.2009
   PubMed Web of Science ®Google Scholar
• Sztuka K, Jasińska-Stroschein M. Animal models of pulmonary arterial hypertension: A systematic review and meta-analysis of data from 6126 animals. Pharmacol Res. 2017;125(Pt B):201–214. doi:10.1016/j.phrs.2017.08.003
   PubMedGoogle Scholar
• Batool M, Berghausen EM, Zierden M, et al. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice. Basic Res Cardiol. 2020;115(6):68. doi:10.1007/s00395-020-00826-8
   PubMed Web of Science ®Google Scholar
• Ryanto GRT, Ikeda K, Miyagawa K, et al. An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension. Nat Commun. 2021;12(1):1720. doi:10.1038/s41467-021-21961-3
   PubMed Web of Science ®Google Scholar
• Wang J, Yu M, Xu J, et al. Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension. J Biomed Sci. 2019;26(1):6. doi:10.1186/s12929-019-0496-y
   PubMedGoogle Scholar
• Irwin DC, Baek JH, Hassell K, et al. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration. Free Radic Biol Med. 2015;82:50–62. doi:10.1016/j.freeradbiomed.2015.01.012
   PubMed Web of Science ®Google Scholar
• Ban Y, Liu Y, Li Y, et al. S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension. Redox Biol. 2019;21:101099. doi:10.1016/j.redox.2019.101099
   PubMed Web of Science ®Google Scholar
• Chen M, Cai H, Yu C, et al. Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKα1-dependent pathways. Am J Transl Res. 2016;8(1):12–27.
   PubMed Web of Science ®Google Scholar
• Ma TT, Wang Y, Zhou XL, et al. Research on rat models of hypobaric hypoxia-induced pulmonary hypertension. Eur Rev Med Pharmacol Sci. 2015;19(19):3723–3730.
   PubMed Web of Science ®Google Scholar
• Huang L, Li H, Huang S, et al. Notopterol attenuates monocrotaline-induced pulmonary arterial hypertension in rat. Front Cardiovasc Med. 2022;9:859422. doi:10.3389/fcvm.2022.859422
   PubMed Web of Science ®Google Scholar
• Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol. 2008;51(16):1527–1538. doi:10.1016/j.jacc.2008.01.024
   PubMed Web of Science ®Google Scholar
• Guignabert C, Dorfmuller P. Pathology and pathobiology of pulmonary hypertension. Semin Respir Crit Care Med. 2013;34(5):551–559. doi:10.1055/s-0033-1356496
   PubMed Web of Science ®Google Scholar
• Hislop A, Reid L. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol. 1976;57(5):542–554.
   PubMedGoogle Scholar
• Cai G, Liu J, Wang M, et al. Mutual promotion of FGF21 and PPARγ attenuates hypoxia-induced pulmonary hypertension. Exp Biol Med (Maywood). 2019;244(3):252–261. doi:10.1177/1535370219828692
   PubMed Web of Science ®Google Scholar